Colgate-Palmolive Company (CL) Position Decreased by Folger Nolan Fleming Douglas Capital Management Inc.
Folger Nolan Fleming Douglas Capital Management Inc. lessened its holdings in Colgate-Palmolive Company (NYSE:CL) by 0.5% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 11,447 shares of the company’s stock after selling 58 shares during the period. Folger Nolan Fleming Douglas Capital Management Inc.’s holdings in Colgate-Palmolive were worth $849,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors have also made changes to their positions in the stock. Pacer Advisors Inc. increased its stake in Colgate-Palmolive by 8.4% during the 2nd quarter. Pacer Advisors Inc. now owns 20,224 shares of the company’s stock worth $1,499,000 after buying an additional 1,566 shares in the last quarter. Alliancebernstein L.P. increased its stake in Colgate-Palmolive by 4.2% during the 1st quarter. Alliancebernstein L.P. now owns 1,899,356 shares of the company’s stock worth $139,014,000 after buying an additional 77,414 shares in the last quarter. Israel Discount Bank of New York purchased a new stake in Colgate-Palmolive during the 1st quarter worth approximately $1,349,000. Principal Financial Group Inc. increased its stake in Colgate-Palmolive by 0.6% during the 1st quarter. Principal Financial Group Inc. now owns 1,271,008 shares of the company’s stock worth $93,025,000 after buying an additional 7,905 shares in the last quarter. Finally, Personal Capital Advisors Corp increased its stake in Colgate-Palmolive by 5.8% during the 2nd quarter. Personal Capital Advisors Corp now owns 394,028 shares of the company’s stock worth $29,209,000 after buying an additional 21,456 shares in the last quarter. Hedge funds and other institutional investors own 73.46% of the company’s stock.
CL has been the topic of several recent research reports. Zacks Investment Research upgraded Colgate-Palmolive from a “sell” rating to a “hold” rating in a report on Wednesday, November 8th. Citigroup Inc. lowered their target price on Colgate-Palmolive from $76.00 to $75.00 and set a “neutral” rating on the stock in a report on Thursday, November 2nd. Morgan Stanley lowered their target price on Colgate-Palmolive from $84.00 to $83.00 and set an “overweight” rating on the stock in a report on Tuesday, October 31st. Jefferies Group LLC lowered their target price on Colgate-Palmolive from $79.00 to $76.00 and set a “hold” rating on the stock in a report on Monday, October 30th. Finally, Stifel Nicolaus set a $73.00 target price on Colgate-Palmolive and gave the stock a “hold” rating in a report on Sunday, October 29th. One investment analyst has rated the stock with a sell rating, fifteen have issued a hold rating and four have issued a buy rating to the company. The company currently has an average rating of “Hold” and an average price target of $76.67.
Colgate-Palmolive Company (NYSE CL) opened at $71.89 on Monday. The company has a debt-to-equity ratio of 24.42, a quick ratio of 0.92 and a current ratio of 1.23. Colgate-Palmolive Company has a 52 week low of $63.43 and a 52 week high of $77.27. The company has a market capitalization of $63,126.98, a price-to-earnings ratio of 25.05, a price-to-earnings-growth ratio of 3.29 and a beta of 0.80.
Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, October 27th. The company reported $0.73 EPS for the quarter, hitting analysts’ consensus estimates of $0.73. Colgate-Palmolive had a return on equity of 2,782.56% and a net margin of 15.10%. The company had revenue of $3.97 billion for the quarter, compared to analysts’ expectations of $3.94 billion. During the same period in the prior year, the firm earned $0.73 earnings per share. The firm’s revenue was up 2.8% compared to the same quarter last year. sell-side analysts predict that Colgate-Palmolive Company will post 2.88 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which was paid on Wednesday, November 15th. Shareholders of record on Monday, October 23rd were paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 2.23%. The ex-dividend date was Friday, October 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is 61.78%.
In other Colgate-Palmolive news, insider Victoria L. Dolan sold 9,000 shares of the company’s stock in a transaction on Tuesday, November 14th. The stock was sold at an average price of $73.41, for a total transaction of $660,690.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CMO Mukul Deoras sold 7,500 shares of the company’s stock in a transaction on Friday, November 10th. The stock was sold at an average price of $73.28, for a total value of $549,600.00. Following the transaction, the chief marketing officer now owns 45,217 shares in the company, valued at $3,313,501.76. The disclosure for this sale can be found here. Insiders have sold 173,673 shares of company stock worth $12,629,293 over the last 90 days. 1.02% of the stock is owned by insiders.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with Analyst Ratings Network's FREE daily email newsletter.